| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.9M | -60.7% |
| R&D Expense | $36.4M | -36.3% |
| SG&A Expense | $16.4M | -4.1% |
| Operating Income | -$28.9M | -115.9% |
| Interest Expense | $302K | +2.4% |
| Pre-tax Income | -$18.7M | -9.2% |
| Income Tax | $26K | — |
| Net Income | -$18.7M | -9.3% |
| EPS (Basic) | -$0.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.0M | -54.7% |
| Accounts Receivable | $5.6M | -30.6% |
| Current Assets | $22.1M | -54.4% |
| Total Assets | $50.9M | -35.9% |
| Current Liabilities | $15.0M | -39.3% |
| Total Liabilities | $19.8M | -51.4% |
| Stockholders' Equity | $31.1M | -19.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.5M | -724.2% |
| Capital Expenditures | $2.2M | -80.2% |
| Investing Cash Flow | -$2.1M | +80.9% |
| Financing Cash Flow | $1.1M | -96.9% |
| Free Cash Flow | -$25.6M | -256.7% |
| +31.7% |